“In addition, the mRNA expression ratio of osteoprotegerin and the receptor activator of nuclear … also dramatically increased by treatment with vitamin K1 (62%), menaquinone-4 (247%), and menaquinone-7 (… vitamin K may suppress the formation of osteoclast by up-regulating …/receptor activator of nuclear factor-kB ligand in osteoblasts.”